The first patient was injected with the experimental cancer-killing virus in a new clinical trial in 2022.
Cancer-killing Virus, The drug candidate CF33-hNIS, also known as Vaxinia, is an oncolytic virus. According to scientists, it is a genetically engineered virus designed ...